Asian BiomedicinePub Date : 2023-12-28eCollection Date: 2023-12-01DOI: 10.2478/abm-2023-0067
{"title":"The value of platelet/lymphocyte ratio in young patient with acute ischemic stroke.","authors":"","doi":"10.2478/abm-2023-0067","DOIUrl":"10.2478/abm-2023-0067","url":null,"abstract":"","PeriodicalId":8501,"journal":{"name":"Asian Biomedicine","volume":"17 6","pages":"249"},"PeriodicalIF":0.4,"publicationDate":"2023-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10754498/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139073264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mathurot Virojanawat, Somkanya Tungsanga, Leilani Paitoonpong, Pisut Katavetin
{"title":"The dose of the normal saline pre-infusion and other risk factors for amphotericin B deoxycholate-associated acute kidney injury","authors":"Mathurot Virojanawat, Somkanya Tungsanga, Leilani Paitoonpong, Pisut Katavetin","doi":"10.2478/abm-2023-0071","DOIUrl":"https://doi.org/10.2478/abm-2023-0071","url":null,"abstract":"Background Conventional amphotericin B deoxycholate (AmBd) is the preferred amphotericin B formulation in countries with limited resources despite its nephrotoxicity. Normal saline pre-infusion is a recommended measure to reduce the risk of nephrotoxicity in patients receiving AmBd. Objectives To examine the effect of different normal saline solution (NSS) pre-infusion doses, and other potential risk factors, on the development of acute kidney injury (AKI) in patients with invasive fungal infection receiving AmBd. Methods Adult patients with invasive fungal infections who received intravenous AmBd were included in this retrospective study. Doses of the normal saline pre-infusion were adjusted to the body weight (NSS/BW) and the daily dose of amphotericin B (NSS/AmBd). Kaplan–Meier survival analysis was used to estimate 14 d AKI-free survival rates, and the log-rank test was used to compare AKI-free survivals between groups. Results The present study included 60 patients; 31 patients developed AKI during the AmBd therapy. The overall 14 d AKI-free survival was 48.3%. NSS/AmBd, but not NSS/BW, was associated with AKI-free survival in patients receiving AmBd: the higher the NSS/AmBd, the higher the AKI-free survival. Gender, baseline blood urea nitrogen (BUN), and baseline plasma bicarbonate (Bicarb) also affected AKI-free survival. Female gender, higher BUN, and lower Bicarb were associated with higher AKI-free survival. Conclusions The present study suggests that low NSS/AmBd, male gender, low BUN, and high Bicarb are risk factors for AmBd-associated AKI. Excluding gender, these risk factors are potentially modifiable and would guide tailoring appropriate preventive measures for AmBd-associated AKI.","PeriodicalId":8501,"journal":{"name":"Asian Biomedicine","volume":"13 1","pages":""},"PeriodicalIF":0.6,"publicationDate":"2023-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139072192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Huijun Wen, Ning Wang, Min Lv, Yue Yang, Hongmei Liu
{"title":"The early predictive value of platelet-to-lymphocyte ratio to hemorrhagic transformation of young acute ischemic stroke","authors":"Huijun Wen, Ning Wang, Min Lv, Yue Yang, Hongmei Liu","doi":"10.2478/abm-2023-0069","DOIUrl":"https://doi.org/10.2478/abm-2023-0069","url":null,"abstract":"Background The increasing incidence of acute ischemic stroke (AIS) necessitates a comprehensive understanding of the related factors. Hemorrhagic transformation (HT), a severe complication of AIS, is influenced by platelet-induced inflammation and lymphocyte levels. Objective To measure the predictive value of platelet-to-lymphocyte ratio (PLR) in the occurrence of HT in young AIS patients. Methods Data of young AIS patients (n = 157) admitted to the hospital for the first time were retrospectively collected. The patients were divided into HT (63 patients) and non-HT groups (94 patients) on the basis of whether HT had occurred after admission. The National Institute of Health stroke scale (NIHSS) score was used to determine the severity of clinical symptoms. The relationship between PLR and HT and NIHSS scores was analyzed to evaluate the predictive value of PLR in the occurrence of HT using receiver operating characteristic (ROC) and area under the curve (AUC). Results Multivariate analysis showed that PLR and NIHSS are independent risk factors of HT. The PLR value of the observation group was positively associated with the NIHSS score (<jats:italic>r</jats:italic> = 0.8075, <jats:italic>P</jats:italic> < 0.0001). According to the PLR prediction about the occurrence of HT, an AUC of 0.713 (95% CI, 0.652–0.781), a cut-off value of 109.073, and a sensitivity and specificity of 0.806 and 0.674, respectively, were obtained. Conclusions PLR value can predict the possibility of HT in young AIS patients to a certain extent. To take effective measures to prevent HT in advance has crucial clinical significance according to PLR value.","PeriodicalId":8501,"journal":{"name":"Asian Biomedicine","volume":"97 1","pages":""},"PeriodicalIF":0.6,"publicationDate":"2023-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139068180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Asian BiomedicinePub Date : 2023-10-26eCollection Date: 2023-10-01DOI: 10.2478/abm-2023-0066
Ling Lu, Sujuan Hu, Gaoyan Wang, Rong Jin, Renzheng Guan, Fengjing Cui, Zhenghai Qu, Dongyun Liu
{"title":"Congenital pulmonary hypoplasia combined with congenital cardiac disease and ectopic kidney: a case report.","authors":"Ling Lu, Sujuan Hu, Gaoyan Wang, Rong Jin, Renzheng Guan, Fengjing Cui, Zhenghai Qu, Dongyun Liu","doi":"10.2478/abm-2023-0066","DOIUrl":"https://doi.org/10.2478/abm-2023-0066","url":null,"abstract":"<p><strong>Background: </strong>Congenital pulmonary hypoplasia (CPH) is a rare pulmonary disease featured by incomplete development of pulmonary tissues. Its diagnosis is still a challenge as patients are usually misdiagnosed as atelectasis.</p><p><strong>Case presentation: </strong>A female neonate was admitted to our hospital due to post-birth jaundice for 12 hrs. Physical examination showed accelerated breathing. There was no respiratory sound in the left lung. Chest film indicated decline of lucency in the left lung. Chest CT scan indicated absence of left lung and primary bronchus of the left lung. The boundary between left mediastinum was not clearly displayed. Three-dimensional CT scan indicated absence of left lung and left principal bronchus. Cardiac ultrasonography confirmed congenital heart disease. She showed ectopic kidney. Finally, she was diagnosed with CPH concurrent with congenital heart disease and ectopic kidney.</p><p><strong>Conclusions: </strong>On 17-month follow-up visit, the patient is still survived, but she presents with obstruction in ventilation function.</p>","PeriodicalId":8501,"journal":{"name":"Asian Biomedicine","volume":"17 5","pages":"244-248"},"PeriodicalIF":0.6,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602632/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71410377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Enhanced external counterpulsation, focusing on its effect on kidney function, and utilization in patients with kidney diseases: a systematic review.","authors":"Thana Thongsricome, Weerapat Kositanurit, Sarawut Siwamogsatham, Khajohn Tiranathanagul","doi":"10.2478/abm-2023-0062","DOIUrl":"10.2478/abm-2023-0062","url":null,"abstract":"<p><strong>Background: </strong>Enhanced external counterpulsation (EECP) is provided by a noninvasive device positively affecting cardiovascular function via mechanisms called diastolic augmentation and systolic unloading. The renal aspects of EECP therapy have not been extensively investigated.</p><p><strong>Objectives: </strong>To assess the effect of EECP on renal function and to determine the application in patients with kidney disease.</p><p><strong>Methods: </strong>MEDLINE, EMBASE, SCOPUS, and Cochrane CENTRAL databases were searched for all studies involving EECP treatments. The title and abstract of all searched literatures were screened, and those focusing on renal outcome or conducting in kidney disease patients were selected.</p><p><strong>Results: </strong>Eight studies were included in the qualitative analysis. EECP increases stroke volume, mean arterial pressure, renal artery blood flow, renal plasma flow, glomerular filtration rate (GFR), plasma atrial natriuretic peptide, urine volume, and urinary sodium chloride excretion, but reduces the plasma concentration of renin and endothelin-1 in healthy subjects. A single session of EECP after radioactive contrast exposure could provide increased contrast clearance, and this reduces contrast-induced kidney injury in patients, irrespective of previous kidney function. Thirty-five-hour sessions of EECP treatment were illustrated to increase long-term estimated GFR in patients with chronic angina and heart failure. In cirrhotic patients, EECP fails to improve GFR and renal vascular resistance. EECP device could maintain blood pressure, decrease angina symptoms, and increase cardiac perfusion in hemodialysis patients.</p><p><strong>Conclusion: </strong>EECP treatment potentially increases renal perfusion and prevents kidney injury in several conditions. EECP possibly provides beneficial effects on hemodynamics and cardiac function in hemodialysis patients.</p>","PeriodicalId":8501,"journal":{"name":"Asian Biomedicine","volume":"17 5","pages":"208-221"},"PeriodicalIF":0.4,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602636/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71410390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Asian BiomedicinePub Date : 2023-10-26eCollection Date: 2023-10-01DOI: 10.2478/abm-2023-0063
Tuyet Thi Vi Le, Nghia Thi Hieu Phan, Ha Le Bao Tran
{"title":"Alginate-gelatin hydrogel supplemented with platelet concentrates can be used as bioinks for scaffold printing.","authors":"Tuyet Thi Vi Le, Nghia Thi Hieu Phan, Ha Le Bao Tran","doi":"10.2478/abm-2023-0063","DOIUrl":"https://doi.org/10.2478/abm-2023-0063","url":null,"abstract":"<p><strong>Background: </strong>Owing to the growing global demand for organ replacement and tissue regeneration, three-dimensional (3D) printing is widely recognized as an essential technology in tissue engineering. Biomaterials become a potential source of raw materials for printing ink by containing factors that promote tissue regeneration. Platelet concentrates are autologous biological products that are capable of doing that.</p><p><strong>Objectives: </strong>This study was carried out to create bioinks capable of providing biological signals by combining gelatin-alginate with platelet concentrates.</p><p><strong>Methods: </strong>This study combined platelet concentrates, including platelet-rich plasma (PRP) and platelet-rich fibrin (PRF), with gelatin and alginate to create bioinks. Bioink properties, including gelatinization and pH, were assessed before printing. After that, the scaffolds were done, and the growth factor (GF) release and cytotoxicity from these scaffolds were performed.</p><p><strong>Results: </strong>Results showed that all the three bioinks, including alginate-gelatin (AG), alginate-gelatin-PRP (AGP), and alginate-gelatin-PRF (AGF) were gelatinized right at the end of bioink fabrication and had a pH around 7. The scaffolds from bioinks supplemented with platelet concentrates secreted GFs that remained for 12 d, and the extracts from them were not cytotoxic for the L929 cell line.</p><p><strong>Conclusion: </strong>In summary, bioinks were made by combining AG with platelet concentrates and had properties suitable for creating scaffolds with cell-oriented grafts in the development of artificial tissues and organs.</p>","PeriodicalId":8501,"journal":{"name":"Asian Biomedicine","volume":"17 5","pages":"222-229"},"PeriodicalIF":0.6,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602633/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71410376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Asian BiomedicinePub Date : 2023-10-26eCollection Date: 2023-10-01DOI: 10.2478/abm-2023-0061
{"title":"Hypertension, preeclampsia, and HELLP syndrome in pregnancy.","authors":"","doi":"10.2478/abm-2023-0061","DOIUrl":"10.2478/abm-2023-0061","url":null,"abstract":"","PeriodicalId":8501,"journal":{"name":"Asian Biomedicine","volume":"17 5","pages":"206-207"},"PeriodicalIF":0.4,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602631/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71410392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Asian BiomedicinePub Date : 2023-10-26eCollection Date: 2023-10-01DOI: 10.2478/abm-2023-0064
Gongchao Huang, Wenqin Zhang, Hongqi Tian
{"title":"Evaluation of the radiosensitizing effect of MEK inhibitor KZ-001 on non-small cell lung cancer cells in vitro.","authors":"Gongchao Huang, Wenqin Zhang, Hongqi Tian","doi":"10.2478/abm-2023-0064","DOIUrl":"https://doi.org/10.2478/abm-2023-0064","url":null,"abstract":"<p><strong>Background: </strong>Non-small cell lung cancer (NSCLC) has a poor prognosis and usually presents resistance against radiotherapy. MEK inhibitors have been proven to possess a radiosensitization effect. The compound KZ-001 as a particular MEK inhibitor is superior to the listed MEK inhibitor AZD6244.</p><p><strong>Objective: </strong>To investigate whether KZ-001 could enhance the radiosensitivity of NSCLC cell lines in vitro.</p><p><strong>Methods: </strong>MTT and colony formation assay were used to evaluate the radiosensitivity effect of KZ-001. Immunofluorescence, cell cycle, apoptosis staining, and western blot experiments were used to explore the radiosensitivity mechanism.</p><p><strong>Results: </strong>KZ-001 significantly decreased A549 cell viability at 6 Gy and 8 Gy radiation doses and caused the radiosensitivity at 1 Gy, 4 Gy, and 6 Gy in colony formation experiments. The A549 apoptosis ratio induced by irradiation (IR) combined with KZ-001 increased significantly in comparison with that by IR monotherapy (10.57% vs. 6.23%, <i>P</i> = 0.0055). The anti-apoptosis marker Bcl-XL was found downregulated in KZ-001 and IR-treated A549/H460 cells, but apoptosis marker Bax was downregulated in H460. Extracellular regulated protein kinases (ERK1/2) phosphorylation of H460 cells could be blocked both by IR alone and IR combined with KZ-001. IR combined with KZ-001 is able to inhibit ERK activation of A549 cells apparently. KZ-001 increased the proportion of G2 phase in irradiated cells from 21.24% to 32.22%. KZ-001 could also significantly increase the double-strand break damage cell ratio to more than 30% compared to the irradiation alone group.</p><p><strong>Conclusions: </strong>MEK1/2 inhibitor KZ-001 is a potential radiosensitizer for clinical applications.</p>","PeriodicalId":8501,"journal":{"name":"Asian Biomedicine","volume":"17 5","pages":"230-237"},"PeriodicalIF":0.6,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602635/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71410391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Asian BiomedicinePub Date : 2023-10-26eCollection Date: 2023-10-01DOI: 10.2478/abm-2023-0065
Yusuf Nergiz, Engin Deveci, Erdal Sak, Sıddık Evsen, Selçuk Tunik, Şebnem Nergiz, Fırat Aşır, Uğur Şeker
{"title":"Severe preeclampsia complicated by HELLP syndrome alters the structure of Hofbauer and syncytiotrophoblast cells: ultrastructural and immunohistochemical study.","authors":"Yusuf Nergiz, Engin Deveci, Erdal Sak, Sıddık Evsen, Selçuk Tunik, Şebnem Nergiz, Fırat Aşır, Uğur Şeker","doi":"10.2478/abm-2023-0065","DOIUrl":"https://doi.org/10.2478/abm-2023-0065","url":null,"abstract":"<p><strong>Background: </strong>Hemolysis, elevated liver enzymes, low platelet count (HELLP) syndrome is generally considered to be a variant or complication of preeclampsia. It is a life-threatening obstetric complication.</p><p><strong>Objectives: </strong>To evaluate the immunohistochemistry and ultrastructural of syncytiotrophoblastand Hoffbauer cells in placental villi of patients with HELLP syndrome.</p><p><strong>Methods: </strong>Two groups of patients with a total of 50 full-term human placentas (n = 25 in each group) were assigned as the control (normotensive) and HELLP syndrome. Placental tissue samples were fixed in 10% neutral formalin and paraffin-embedding protocol was performed. We prepared 5 μm sections for histological and immunohistochemical staining. Sections were immunostained with Hoffbauer cell marker CD68. For transmission electron microscopy (TEM), placental tissue samples were fixed in 2.5% buffered glutaraldehyde and then, in 1% osmium tetroxide for routine ultrastructural examinations.</p><p><strong>Results: </strong>When the HELLP group fetal placental sections were examined, intracytoplasmic edema in syncytiotrophoblast, degenerative vacuoles, and degenerative findings on cell surface membranes were observed. Moreover, villous edema was remarkable. The number of CD68-positive Hoffbauer cells per villus control group sections was 0.23 ± 0.02 and the number of CD68-positive cells per villus in HELLP group placenta sections was 0.83 ± 0.12. The increase in the number of Hoffbauer cells per villus in the HELLP group was significant (<i>P</i> < 0.001). Compared with the control group, there was a significant increase in the number of Hoffbauer cells and syncytiotrophoblasts in the HELLP group, and degenerative changes were also observed in the ultrastructure of these cells.</p><p><strong>Conclusions: </strong>Pathology of the HELLP syndrome is in relation to CD68-positive placental macrophages.</p>","PeriodicalId":8501,"journal":{"name":"Asian Biomedicine","volume":"17 5","pages":"238-243"},"PeriodicalIF":0.6,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602634/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71410393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Asian BiomedicinePub Date : 2023-10-18eCollection Date: 2023-08-01DOI: 10.2478/abm-2023-0060
Bhoowit Lerttiendamrong, Pavinee Annoppornchai, Pasu Promniyom
{"title":"Fibrosarcomatous dermatofibrosarcoma protuberans: a rapidly growing 30 cm mass on the posterior scalp.","authors":"Bhoowit Lerttiendamrong, Pavinee Annoppornchai, Pasu Promniyom","doi":"10.2478/abm-2023-0060","DOIUrl":"https://doi.org/10.2478/abm-2023-0060","url":null,"abstract":"<p><p>Dermatofibrosarcoma protuberans (DFSP) is a rare, slow-growing sarcoma of the skin and subcutaneous tissue, accounting for around 5 cases per million per year. Fibrosarcomatous transformation of DFSP occurs in 10%-15% of DFSP cases, with a higher risk of local recurrence, metastasis, and death. We present a case of a male in his 30s with a complaint of rapidly progressive mass in the occipital region of the head. Within 1 year, the mass enlarged by >30 cm. Physical examination revealed a skin-colored 40×30 cm mass with an overlying skin necrosis at the posterior scalp. Brain, neck, and chest computed tomography (CT) scans were performed. The mass was surgically excised by wide excision with a 2 cm margin. Pathological report confirmed fibrosarcomatous DFSP Grade 3 with decreased CD34 expression. Delayed reconstruction of free flap and split-thickness skin graft were subsequently performed. No recurrence was detected 3 months postoperatively.</p>","PeriodicalId":8501,"journal":{"name":"Asian Biomedicine","volume":"17 4","pages":"200-205"},"PeriodicalIF":0.6,"publicationDate":"2023-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10584390/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49673790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}